Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sienna Biopharmaceuticals Inc SNNAQ

Healthcare Biotechnology
Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on bringing scientific innovations to patients whose lives remain burdened by their disease. Its lead candidate from its platform, SNA-120, is an inhibitor of Tropomyosin receptor kinase A (TrkA) for the treatment of psoriasis, as well as the associated pruritus (itch). The Company's second... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:SNNAQ)

Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna Biopharmaceuticals

PR Newswire January 9, 2020

Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures

GlobeNewswire November 14, 2019

Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting Notice

GlobeNewswire November 14, 2019

Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove Light Hair

GlobeNewswire October 7, 2019

Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding

GlobeNewswire September 17, 2019

Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives

GlobeNewswire August 5, 2019

Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference

GlobeNewswire June 20, 2019

Sienna Biopharmaceuticals Announces Late-Breaking Oral Presentation of Phase 2b Trial Results of its Topical, Non-Steroidal TrkA Inhibitor SNA-120 (0.05%) at 24th World Congress of Dermatology

GlobeNewswire June 10, 2019

Sienna Biopharmaceuticals to Present at Dermatology Drug Development Summit Europe

GlobeNewswire May 21, 2019
View More News ››

Opinion & Analysis (GREY:SNNAQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:SNNAQ)

this stock was

a tax loss sell for me,it was a gamble that didn't work out but basically got my money back from it,if you get greedy it usually...
coolfooldumbguy - December 19, 2019

still holding this stock

should have sold it yesterday for a double because it was beat up badly today,but it was a gamble, so glta.
coolfooldumbguy - December 17, 2019

still holding this stock

it's a gamble,but it looks like a rebound is in the cards,because every penny it goes up is a penny of profit for me,so glta.
coolfooldumbguy - December 16, 2019

it's a buy today for me

a big block at this .075 cents per share,it is a gamble for me,so glta speculators.
coolfooldumbguy - December 12, 2019
View more Bullboard ››

Nurcapital Corp Ltd

Nurcapital Corp Ltd

Nurcapital Corporation Ltd. is a Canada-based capital pool company. The Company is engaged in identifying and evaluating ...
View More »